TrialAdvances in therapy2024

Exposure-Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome.

Mona Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.